A phase III, randomized, controlled, open label,
no profit, single-center intervention study to
compare the effect of a conservative
(antithyroid drugs) and an ablative
approach (radioiodine or total
thyroidectomy) for the treatment of
hyperthyroidism in patients with Graves’
disease and moderate-to-severe and active
Graves’ Orbitopathy (GO) treated with
intravenous glucocorticoids (ABLAGO Study)
Not yet recruitingCTIS2024-518452-23-00
Azienda Ospedaliero Universitaria PisanaGraves' disease and Graves' orbitophaty
Target: 52Updated: 2024-11-19